In PD Participants, Greater Prevalence of Non‐Motor Symptoms, Cognitive Impairment, and Hallucinations in GBA1 p.N409S Relative to LRRK2 p.G2019S Carriers. This evidence concerns the gene LRRK2 and Parkinson disease.